{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:45:10Z","timestamp":1784771110344,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["2379"],"award-info":[{"award-number":["2379"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47073-w","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:14:40Z","timestamp":1776424480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Kv1.3 Channel inhibition by nanoformulated MeuKTx as a therapeutic strategy in breast cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Fatemeh","family":"Kazemi-Lomedasht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohre","family":"Eftekhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidar","family":"Safarpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"47073_CR1","doi-asserted-by":"crossref","unstructured":"Giaquinto, A. N. et al. Breast cancer statistics, CA. Cancer J. Clin. 72, 524\u2013541 (2022).","DOI":"10.3322\/caac.21754"},{"key":"47073_CR2","first-page":"477","volume":"74","author":"AN Giaquinto","year":"2024","unstructured":"Giaquinto, A. N. et al. Breast cancer statistics 2024. CA Cancer J. Clin. 74, 477\u2013495 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"47073_CR3","doi-asserted-by":"publisher","first-page":"17414","DOI":"10.1073\/pnas.0605136103","volume":"103","author":"C Beeton","year":"2006","unstructured":"Beeton, C. et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc. Natl. Acad. Sci. 103, 17414\u201317419 (2006).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"47073_CR4","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2147\/OTT.S326614","volume":"15","author":"L Z\u00fa\u00f1iga","year":"2022","unstructured":"Z\u00fa\u00f1iga, L., Cayo, A., Gonz\u00e1lez, W., Vilos, C. & Z\u00fa\u00f1iga, R. Potassium Channels as a Target for Cancer Therapy: Current Perspectives. Onco Targets Ther. 15, 783\u2013797 (2022).","journal-title":"Onco Targets Ther."},{"key":"47073_CR5","doi-asserted-by":"publisher","first-page":"e148118","DOI":"10.1590\/1678-9199-jvatitd-1481-18","volume":"25","author":"IS Oliveira","year":"2019","unstructured":"Oliveira, I. S. et al. Scorpion toxins targeting Kv1.3 channels: insights into immunosuppression. J. Venom. Anim. Toxins Incl. Trop. Dis. 25, e148118 (2019).","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"47073_CR6","doi-asserted-by":"crossref","unstructured":"Payne, S. L. et al. Potassium channel-driven bioelectric signalling regulates metastasis in triple-negative breast cancer. EBioMedicine. 75, 103767 (2022).","DOI":"10.1016\/j.ebiom.2021.103767"},{"key":"47073_CR7","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3389\/fonc.2019.00933","volume":"9","author":"A Teisseyre","year":"2019","unstructured":"Teisseyre, A., Palko-Labuz, A., Sroda-Pomianek, K. & Michalak, K. Voltage-Gated Potassium Channel Kv1.3 as a Target in Therapy of Cancer. Front. Oncol. 9, 933 (2019).","journal-title":"Front. Oncol."},{"key":"47073_CR8","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1177\/2472555219864894","volume":"24","author":"E Prosdocimi","year":"2019","unstructured":"Prosdocimi, E., Checchetto, V. & Leanza, L. Targeting the Mitochondrial Potassium Channel Kv1.3 to Kill Cancer Cells: Drugs, Strategies, and New Perspectives. SLAS Discov. 24, 882\u2013892 (2019).","journal-title":"SLAS Discov"},{"key":"47073_CR9","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1002\/med.21800","volume":"41","author":"\u0160 Gubi\u010d","year":"2021","unstructured":"Gubi\u010d, \u0160. et al. Discovery of K(V) 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges. Med. Res. Rev. 41, 2423\u20132473 (2021).","journal-title":"Med. Res. Rev."},{"key":"47073_CR10","doi-asserted-by":"publisher","first-page":"116651","DOI":"10.1016\/j.biopha.2024.116651","volume":"175","author":"S Cheng","year":"2024","unstructured":"Cheng, S., Jiang, D., Lan, X., Liu, K. & Fan, C. Voltage-gated potassium channel 1.3: A promising molecular target in multiple disease therapy. Biomed. Pharmacother. 175, 116651 (2024).","journal-title":"Biomed. Pharmacother"},{"key":"47073_CR11","doi-asserted-by":"publisher","unstructured":"Bartok, A. et al. (eds) in (., E. & Rodr\u00edguez de la Vega, R. C.) 493\u2013527 (Springer Netherlands, (2015). https:\/\/doi.org\/10.1007\/978-94-007-6404-0_30","DOI":"10.1007\/978-94-007-6404-0_30"},{"key":"47073_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.toxicon.2012.10.010","volume":"61","author":"E Diego-Garc\u00eda","year":"2012","unstructured":"Diego-Garc\u00eda, E. et al. Novel Potassium Channel Blocker Venom Peptides from Mesobuthus gibbosus (Scorpiones: Buthidae). Toxicon. 61, 72\u201382 (2012).","journal-title":"Toxicon"},{"key":"47073_CR13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.7150\/thno.103384","volume":"15","author":"Q Shi","year":"2025","unstructured":"Shi, Q. et al. Targeting ion channels: innovative approaches to combat cancer drug resistance. Theranostics 15, 521 (2025).","journal-title":"Theranostics"},{"key":"47073_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/jcp.1041650121","volume":"165","author":"WF Wonderlin","year":"1995","unstructured":"Wonderlin, W. F., Woodfork, K. A. & Strobl, J. S. Changes in membrane potential during the progression of MCF-7 human mammary tumor cells through the cell cycle. J. Cell. Physiol. 165, 177\u2013185 (1995).","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"47073_CR15","doi-asserted-by":"publisher","first-page":"115817","DOI":"10.1016\/j.intimp.2025.115817","volume":"168","author":"Kazemi-Lomedasht","year":"2026","unstructured":"Kazemi-Lomedasht, Eftekhari, Z., Chiani, M., Ramezanpour, S. & Montazeri, A. Ameliorative effects of chitosan nanoparticles containing a scorpion-derived potassium channel inhibitory peptide (alpha-KTx 3.13) in a juvenile model of rheumatoid arthritis. Int. Immunopharmacol. 168 (2), 115817 (2026).","journal-title":"Int. Immunopharmacol."},{"key":"47073_CR16","doi-asserted-by":"publisher","first-page":"100040","DOI":"10.1016\/j.ntm.2024.100040","volume":"3","author":"AK Grewal","year":"2024","unstructured":"Grewal, A. K. & Salar, R. K. Chitosan nanoparticle delivery systems: an effective approach to enhancing efficacy and safety of anticancer drugs. Nano TransMed. 3, 100040 (2024).","journal-title":"Nano TransMed"},{"key":"47073_CR17","doi-asserted-by":"publisher","first-page":"106554","DOI":"10.1016\/j.intimp.2020.106554","volume":"85","author":"N Jabbari","year":"2020","unstructured":"Jabbari, N., Eftekhari, Z., Roodbari, N. H. & Parivar, K. Evaluation of Encapsulated Eugenol by Chitosan Nanoparticles on the aggressive model of rheumatoid arthritis. Int. Immunopharmacol. 85, 106554 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"47073_CR18","doi-asserted-by":"publisher","first-page":"110789","DOI":"10.1016\/j.foodhyd.2024.110789","volume":"160","author":"Y Atma","year":"2025","unstructured":"Atma, Y., Sadeghpour, A., Murray, B. S. & Goycoolea, F. M. Chitosan-alginate polyelectrolyte complexes for encapsulation of low molecular weight fish bioactive peptides. Food Hydrocoll. 160, 110789 (2025).","journal-title":"Food Hydrocoll."},{"key":"47073_CR19","first-page":"234","volume":"10","author":"SS Samavati","year":"2023","unstructured":"Samavati, S. S., Hadizadeh, M., Abedi, M., Rabiei, M. & Derakhshankhah, H. Encapsulation of eucalyptus essential oil in chitosan nanoparticles and its effect on MDA-MB-231 cells. Nanomed. J. 10, 234\u2013244 (2023).","journal-title":"Nanomed. J."},{"key":"47073_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10549-014-3159-4","volume":"148","author":"E Ziegler","year":"2014","unstructured":"Ziegler, E., Hansen, M. T., Haase, M., Emons, G. & Gr\u00fcndker, C. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo. Breast Cancer Res. Treat. 148, 269\u2013277 (2014).","journal-title":"Breast Cancer Res. Treat."},{"key":"47073_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10549-011-1534-y","volume":"132","author":"IK Guttilla","year":"2012","unstructured":"Guttilla, I. K. et al. Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs. Breast Cancer Res. Treat. 132, 75\u201385 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"47073_CR22","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1134\/S106816202402016X","volume":"50","author":"P Eroglu","year":"2024","unstructured":"Eroglu, P. et al. Investigation of the Effect of Tamoxifen on hERG1 Potassium Channel Gene Expression in MCF-7 Cell Line. Russ J. Bioorg. Chem. 50, 392\u2013400 (2024).","journal-title":"Russ J. Bioorg. Chem."},{"key":"47073_CR23","doi-asserted-by":"crossref","unstructured":"Kumar, P., Nagarajan, A. & Uchil, P. D. Analysis of cell viability by the MTT assay. Cold spring Harb. Protoc. pdb-prot095505 (2018).","DOI":"10.1101\/pdb.prot095505"},{"key":"47073_CR24","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.3390\/ma14143858","volume":"14","author":"K G\u0119bczak","year":"2021","unstructured":"G\u0119bczak, K., Wiatrak, B. & Fortuna, W. Evaluation of PC12 Cells\u2019 Proliferation, Adhesion and Migration with the Use of an Extracellular Matrix (CorMatrix) for Application in Neural Tissue Engineering. Mater. (Basel Switzerland). 14, 3858 (2021).","journal-title":"Mater. (Basel Switzerland)"},{"key":"47073_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fcell.2019.00107","volume":"7","author":"J Pijuan","year":"2019","unstructured":"Pijuan, J. et al. In vitro Cell Migration, Invasion, and Adhesion Assays: From Cell Imaging to Data Analysis. Front. cell. Dev. Biol. 7, 107 (2019).","journal-title":"Front. cell. Dev. Biol."},{"key":"47073_CR26","doi-asserted-by":"publisher","first-page":"17876","DOI":"10.1038\/s41598-025-03113-5","volume":"15","author":"Y Xue","year":"2025","unstructured":"Xue, Y. et al. Exosomes derived from M2 macrophage promote HUVECs proliferation, migration and tube formation in vitro. Sci. Rep. 15, 17876 (2025).","journal-title":"Sci. Rep."},{"key":"47073_CR27","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1158\/0008-5472.CAN-13-2033","volume":"74","author":"W Fiskus","year":"2014","unstructured":"Fiskus, W. et al. Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia. Cancer Res. 74, 2520\u20132532 (2014).","journal-title":"Cancer Res."},{"key":"47073_CR28","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.ijbiomac.2018.01.144","volume":"111","author":"D Aissaoui","year":"2018","unstructured":"Aissaoui, D. et al. Functional role of Kv1.1 and Kv1.3 channels in the neoplastic progression steps of three cancer cell lines, elucidated by scorpion peptides. Int. J. Biol. Macromol. 111, 1146\u20131155 (2018).","journal-title":"Int. J. Biol. Macromol."},{"key":"47073_CR29","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/md13010529","volume":"13","author":"MW Pennington","year":"2015","unstructured":"Pennington, M. W. et al. Development of highly selective Kv1.3-blocking peptides based on the sea anemone peptide ShK. Mar. Drugs. 13, 529\u2013542 (2015).","journal-title":"Mar. Drugs"},{"key":"47073_CR30","doi-asserted-by":"publisher","first-page":"101705","DOI":"10.1016\/j.redox.2020.101705","volume":"37","author":"R Peruzzo","year":"2020","unstructured":"Peruzzo, R. et al. Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family. Redox Biol. 37, 101705 (2020).","journal-title":"Redox Biol."},{"key":"47073_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s12935-025-03973-x","volume":"25","author":"Y Chen","year":"2025","unstructured":"Chen, Y., Ding, H., Song, J. & Gao, X. Breast neoplasm epithelial-mesenchymal transition and cytokines: a systematic review. Cancer Cell. Int. 25, 323 (2025).","journal-title":"Cancer Cell. Int."},{"key":"47073_CR32","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.3390\/ijms26094364","volume":"26","author":"S Ghafoor","year":"2025","unstructured":"Ghafoor, S., Garcia, E., Jay, D. J. & Persad, S. Molecular Mechanisms Regulating Epithelial Mesenchymal Transition (EMT) to Promote Cancer Progression. Int. J. Mol. Sci. 26, 4364 (2025).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47073-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47073-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47073-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:05:30Z","timestamp":1781089530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47073-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47073"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47073-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval for all experiments, including the use and authentication of cell lines, was granted by the Ethics Committee of the Pasteur Institute of Iran (approval number IR.PII.REC.1403.017). All procedures were carried out in full compliance with the committee\u2019s guidelines and national ethical regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"17879"}}